Status:
ACTIVE_NOT_RECRUITING
Minimally Invasive Suprachoroidal Drainage for the Treatment of Neovascular Glaucoma
Lead Sponsor:
Zhongnan Hospital
Conditions:
Neovascular Glaucoma
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
To explore the efficacy and safety of minimally invasive suprachoroidal drainage for the treatment of advanced neovascular glaucoma
Detailed Description
To explore the efficacy and safety of minimally invasive supraporcular drainage in the treatment of advanced neovascular glaucoma, and to record the various basic diseases, ocular conditions, lifestyl...
Eligibility Criteria
Inclusion
- Advanced (angle-closure) neovascular glaucoma with poorly controlled intraocular pressure (IOP \> 21mmHg) after medical or surgical treatment
Exclusion
- Various other types of glaucoma (including primary open-angle glaucoma, primary open-closed glaucoma, normal tension glaucoma, juvenile glaucoma, congenital glaucoma, other special types of glaucoma, etc.)
- Eye infection within two weeks before surgery
- Non-glaucomatous intraocular diseases that affect intraocular pressure (choroidal hemorrhage or detachment, retinal detachment, lens subluxation, thyroid eye disease, clinically significant macular edema, eye tumors, etc.)
- Visual acuity of non-study eyes \< 0.05
- Congenital or acquired factors lead to ciliary body anatomical abnormalities
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07201415
Start Date
January 1 2025
End Date
March 1 2027
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China, 430071